Transcription of Public Assessment Report Decentralised Procedure …
{{id}} {{{paragraph}}}
PAR Yaltormin SR 500 mg, 750 mg and 1000 mg Prolonged Release Tablets UK/H/5957/001-3/DC 1 Public Assessment Report Decentralised Procedure Yaltormin SR 500 mg, 750 mg and 1000 mg Prolonged Release Tablets (metformin hydrochloride) Procedure No: UK/H/5957/001-3/DC UK Licence No: PL 29831/0655-0657 Wockhardt UK Ltd PAR Yaltormin SR 500 mg, 750 mg and 1000 mg Prolonged Release Tablets UK/H/5957/001-3/DC 2 LAY SUMMARY Yaltormin SR 500 mg, 750 mg and 1000 mg Prolonged Release Tablets (metformin hydrochloride) This is a summary of the Public Assessment Report (PAR) for Yaltormin SR 500 mg, 750 mg and 1000 mg Prolonged Release Tablets (PL 29831/0655-0657: UK/H/5957/001-3/DC).
PAR Yaltormin SR 500 mg, 750 mg and 1000 mg Prolonged Release Tablets UK/H/5957/001-3/DC 3 sugar produced in the liver and increases the …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}